N on-shivering thermogenesis in brown adipose tissue (BAT) plays an important role in thermoregulatory cold-defense and, through its metabolic consumption of energy reserves to produce heat, can affect the long-term regulation of adiposity. An orexinergic pathway from the perifornical lateral hypothalamus (PeF/LH) to the rostral raphe pallidus (rRPa) has been demonstrated to increase the gain of the excitatory drives to medullary sympathetic premotor neurons controlling BAT sympathetic outflow and BAT thermogenesis. With this background, we consider neural mechanisms that could underlie orexin's modulation of the excitability of BAT sympathetic premotor neurons in rRPa and the potential role of altered BAT thermogenesis in pathological conditions associated with the absence of the central orexin system. Overall, these new data enhance our understanding of the role of central orexin in regulating body temperature and energy homeostasis and provide further insight into the neurochemical regulation of BAT thermogenesis and metabolism.
Introduction
Orexins (hypocretins) are neuropeptides synthesized by neurons in the perifornical region of the lateral hypothalamus (PeF-LH) 1,2 that have widespread projections that position the orexin system to influence a variety of behaviors and physiological functions including sleepwake states and stress-arousal responses, 3, 4 as well as the neuroendocrine, metabolic and autonomic variables engaged during these states. [5] [6] [7] [8] Loss of orexin neurons from the PeF-LH leads to the disordered sleep patterns of narcolepsy and is often accompanied by lethargy and impairments in metabolic homeostasis, including a high risk for obesity 9, 10 and for altered thermoregulation.
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Brown adipose tissue (BAT) is a unique mammalian metabolic furnace that is under the direct control of the sympathetic nervous system 12 and produces heat through the uncoupling of its mitochondrial oxidative phosphorylation. 13 BAT thermogenesis plays a significant role in the maintenance of body temperature and BAT energy consumption contributes to body weight regulation, the importance of which has been recently reinforced with the demonstration of metabolically significant BAT depots in humans and the discovery of a reduced BAT activity in obese persons. [14] [15] [16] Since mammalian, including human, BAT thermogenesis contributes to thermoregulatory and metabolic homeostasis and is altered during the behavioral and state changes with which changes in orexin are also associated, a connection between the orexin system and the central circuits that influence the sympathetic outflow to BAT has been sought.
Establishing a Connection between Orexin Neurotransmission and Central Regulation of BAT
In the study by Tupone and colleagues, 17 anatomical tracing and orexin immunohistochemical localization were combined with in vivo electrophysiological techniques to elucidate a central neural pathway through which orexin neurons influence BAT thermogenesis and energy expenditure in rats. Viral retrograde tracing from BAT and cholera toxin retrograde tracing from the rostral raphe pallidus (rRPa) indicated that a population of orexin neurons in the PeF-LH is synaptically connected to BAT via a direct projection from the PeF-LH to the rRPa. The connection from PeF-LH to neurons in the rRPa is important because the rRPa contains sympathetic premotor neurons whose excitatory drive to BAT sympathetic preganglionic neurons in the thoracic spinal cord determines the sympathetic outflow to BAT and, in turn, the level of BAT metabolism and thermogenesis. In anesthetized, paralyzed and artificially ventilated rats whose core temperature was maintained below 37°C, such that there was a low level of ongoing BAT sympathetic nerve activity (SNA), nanoinjection of orexin-A into the rRPa produced large and sustained increases in BAT sympathetic outflow, in BAT thermogenesis and in heart rate. Activation of neurons in the PeF-LH with nanoinjection of n-methyl-D-aspartate (NMDA) also markedly enhanced BAT SNA and BAT thermogenesis over a long time course. In contrast, in rats that were warmed slightly to core temperatures at which the BAT sympathetic nerve was quiescent, neither nanoinjection of orexin in rRPa nor direct, NMDA-mediated activation of PeF-LH neurons, including those containing orexin, increased BAT SNA or BAT temperature. These results indicate the ability of orexin released from the terminals of orexin neurons in PeF-LH directly into the rRPa to produce a strong potentiation of ongoing BAT SNA, BAT thermogenesis and BAT energy expenditure.
Orexin in rRPa Potentiates the Excitatory Drive to BAT Sympathetic Premotor Neurons
The potentiation of BAT SNA by orexin in the rRPa may be viewed as an increase in the gain of the excitatory inputs to BAT sympathetic premotor neurons in the rRPa-when orexin is released in the rRPa, the level of discharge of BAT sympathetic premotor neurons due to their excitatory inputs is augmented with respect to that in the absence of orexin. On the other hand, if the excitatory drive to BAT sympathetic premotor neurons is low (or the inhibitory inputs are sufficiently high), as in the case of a warm core temperature greater than~37°C, then orexin in rRPa is not capable of augmenting the discharge of BAT sympathetic premotor neurons to a level that results in activity on the sympathetic nerve to BAT. The findings that cooling-evoked (i.e., thermoregulatory) sympathetic outflow to BAT is dependent on glutamate receptor activation in the rRPa 18 and that blockade of local GABA A receptors in the rRPa with bicuculline elicits a potent increase in BAT SNA 19 suggest basic mechanisms that could each contribute to the ability of orexin in the rRPa to increase the gain of the excitatory drive to BAT sympathetic premotor neurons and thereby facilitate ongoing sympathetic activity to BAT and BAT thermogenesis.
First, orexin could bind to orexin receptors on sympathetic premotor neurons (Fig. 1B) , including serotonergic neurons, 20, 21 in rRPa to alter their responsiveness to excitatory synaptic inputs. Orexin has a potent effect at postsynaptic receptors, acting through G-protein coupled receptors to increase cytosolic calcium levels 22 and orexin receptors have been localized on neurons in the rRPa, 23 but there has been no further characterization of the medullary neurons expressing the orexin receptor. We have demonstrated that activation of serotonergic receptors in the spinal cord increases the gain of the spinal thermogenic network by potentiating glutamatergic excitation of BAT sympathetic preganglionic neurons. 24, 25 This result raises the interesting possibility that the BAT excitatory effect of orexin release in the rRPa could reflect a selective stimulation of local serotonergic BAT sympathetic premotor neurons producing a spinal serotonergic potentiation of descending glutamatergic drive to BAT sympathetic preganglionic neurons. Postsynaptic effects of orexin could also be mediated by orexin receptors on local interneurons in the rRPa area that, in turn, affect the activity of BAT sympathetic premotor neurons. Alternatively, orexin could act at orexin receptors on presynaptic terminals (Fig. 1A) to reduce GABA release or increase glutamate release onto BAT sympathetic premotor neurons in rRPa. In this regard, orexin increased the frequency of glutamatergic miniature postsynaptic potentials in the presence of TTX. 22 Interestingly, orexin release in rRPa could increase BAT sympathetic premotor neuron activity by reducing GABA release through an endocannabinoid-mediated retrograde neurotransmission (Fig. 1C) as demonstrated to mediate orexin's antinociceptive effect within the periaqueductal gray. 26 Orexin could presynaptically potentiate glutamate release onto BAT sympathetic premotor neurons in the rRPa, similar to mechanisms suggested for the potentiation of masseter muscle tone with microinjection of orexin into the trigeminal nucleus. 27 However, in the latter experiments, as in ours, if there is a strong dependence on glutamate receptor activation for excitatory transmission through the nucleus in which orexin is being injected, identifying a presynaptic, orexin receptor-mediated mechanism for glutamate release would require in vitro approaches rather than simply demonstrating a reduction in the excitatory effects of orexin by glutamate receptor blockade in vivo.
Potential Physiological Sequelae of the Central Orexin Influence on BAT Thermogenesis
Orexin may play a role in the regulation of the ultradian rhythm of BAT thermogenesis 28, 29 which is characterized in rodents by increases in BAT temperature every~1-2 h during the awake period of the ultradian sleep/wake cycle. 28, 30 Supporting this possibility, the activity of orexinergic neurons and the levels of orexin in the extracellular fluid oscillate with the ultradian sleep/wake cycle, with higher indices of orexin activity during the waking state [31] [32] [33] and ventricular administration of orexin increases BAT temperature. 34 Although an ultradian rhythm in BAT temperature in orexin-null mice has not been assessed, the ultradian sleep/wake cycle of these mice is disrupted, with shorter wakefulness periods than wild-type mice. 30, 35 We postulate that the ultradian increases in BAT temperature are mediated by the periodic release of orexin in the rRPa, resulting in increases in the gain of the BAT thermogenic pathway that increases body and brain temperatures.
Although the functional implications of orexin's ability to increase the gain of the thermogenic neurotransmission in the rRPa remain untested, the close correlation of BAT thermogenesis and the resulting increase in body temperature during periods of wakefulness suggests that BAT thermogenesis may contribute to an enhanced metabolism during periods of wakefulness or arousal that require enhanced performance. Conversely, low levels of thermogenesis during sleep states may act to conserve metabolic resources during a behavioral state in which energy stores are not being replenished. Indeed, by modulating the gain of BAT excitatory neurotransmission in the rRPa, the degree of orexin receptor activation in the rRPa should have a significant influence on the consumption of energy stores in white adipose tissue and thus on the regulation of body weight. Narcolepsy is the neurological disorder attributable to reduced orexin neurotransmission [36] [37] [38] and, although principally characterized by altered sleep/wake cycles, narcolepsy is also associated with obesity in human patients, 9,39-43 despite a reduced caloric intake 44 and a normal total physical activity compared either to healthy control subjects 45 or to patients with idiopathic hypersomnia. 9 Mice that lack orexin neurons also gain more weight than wildtype controls despite reduced food intake; however, a decrease in spontaneous motor activity likely also contributes to their weight gain. 10 Conversely, augmented orexin activity prevents diet-induced obesity and could contribute to a lean phenotype. 46 The excess weight gain in orexin-null mice is attributable to impaired thermogenesis in BAT. 47 Although the potential role for diminished BAT activation in the increased incidence of obesity in narcoleptic patients has not been tested, this hypothesis would be consistent with the recent demonstrations of an inverse relationship between the activity of BAT and body mass index in adult humans [14] [15] [16] and with the overall reduction in BAT energy consumption expected in the absence of orexin. 17 Handling and a variety of other stressful situations for rodents elicit increases in core temperature to which BAT thermogenesis may contribute. 48, 49 Ablation of orexin neurons, but not the absence of orexin per se, reduces the increase in core body temperature evoked by repeated handling stress, indicating that orexin-containing neurons release neurotransmitters other than orexin (e.g., dynorphin or glutamate, which are normally co-expressed in orexin neurons 50, 51 ) to elicit stress-evoked increases in body temperature. 52 However, orexin, likely derived from the placenta, is required for the development and differentiation of BAT and systemic orexin administration during gestation in orexin-null dams rescues this developmental defect in the newborn pups. 47 Thus, the genotype of the dam could determine the development of BAT in the offspring, requiring cautious interpretation of phenotypic data related to BAT thermogenesis from genetically-driven ablation and knockout models of orexinproducing cells. Considering the potential for differences in the development of BAT to contribute to altered body temperature responses, BAT thermogenic competence and UCP-1 expression levels (see refs. 47 vs. 50) must be rigorously assessed.
Summary
An orexinergic input to the rRPa has been demonstrated to potentiate the excitatory drives to medullary sympathetic premotor neurons controlling BAT sympathetic outflow and BAT thermogenesis. These results provide a potential mechanism contributing to the disrupted regulation of body temperature, energy metabolism and body weight in the absence (narcolepsy) or dysregulation of orexin secretion.
